Position
Ethic Inc. in Larimar Therapeutics, Inc.
Back to the book · All holders of LRMR
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $24.5K$3.81 → $4.50
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 68.1K | $259.5K | — | — | — | 0.0% |
| Q1 2026 | 35.5K | $159.5K | $4.50 | $24.5K | −$124.4K | 0.0% |